
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has shown solid performance recently, particularly in Asia, where it benefits from healthy growth and a stable business in wealth management. However, there is concern over potential government-imposed taxes on its products in mainland China. While the stock has performed well, analysts caution that it is currently feeling somewhat overbought, trading at a price-to-earnings ratio above its historical levels, and advise investors to be selective. Consensus analysis suggests good long-term potential due to its decent dividend yield and solid execution in asset management, even as financial conditions such as interest rates fluctuate. Overall, MFC is viewed as a reliable income stock, with room for growth despite being traded at attractive valuations compared to Canadian banks.
Cheaper PE at 8.5x than peers, decent growth rate of 9%. Nice beat recently with Asia up 21%, EPS up 18%, ROE starting to get higher at 16.7%. Helped by rates being higher for longer. Insurance companies still better than the banks, and fund flows continue. Nice yield of 4.5%, with 8% growth.
Ideally, he'd like to buy lower. But can still buy here and it will work for your portfolio over the next 1-2 years.
Debating quality of company within investment team. Sees money coming out of financial sector in Canada - going into insurance companies. Not overly positive on direction of business. If expectations for rate cuts continues - will be good for business. Would recommend investors to hold the position.
De-risked US business, the weakest unit. He's looking at it, on shopping list, hasn't yet pulled trigger. Re-rated nicely, undemanding multiple, single-digit PE ratio. Yield is ~4%. Pay attention to chart validating fundamental changes, often a leading indicator of changes within. Wouldn't quarrel with investors taking a position.